Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing

Milan Radovich, Susan E. Clare, Rutuja Atale, Ivanesa Pardo, Bradley A. Hancock, Jeffrey P. Solzak, Nawal Kassem, Theresa Mathieson, Anna Maria Storniolo, Connie Rufenbarger, Heather A. Lillemoe, Rachel J. Blosser, Mi Ran Choi, Candice A. Sauder, Diane Doxey, Jill E. Henry, Eric E. Hilligoss, Onur Sakarya, Fiona C. Hyland, Matthew HickenbothamJin Zhu, Jarret Glasscock, Sunil Badve, Mircea Ivan, Yunlong Liu, George W. Sledge, Bryan Schneider

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Triple-negative breast cancers (TNBCs) are a heterogeneous set of tumors defined by an absence of actionable therapeutic targets (ER, PR, and HER-2). Microdissected normal ductal epithelium from healthy volunteers represents a novel comparator to reveal insights into TNBC heterogeneity and to inform drug development. Using RNA-sequencing data from our institution and The Cancer Genome Atlas (TCGA) we compared the transcriptomes of 94 TNBCs, 20 microdissected normal breast tissues from healthy volunteers from the Susan G. Komen for the Cure Tissue Bank, and 10 histologically normal tissues adjacent to tumor. Pathway analysis comparing TNBCs to optimized normal controls of microdissected normal epithelium versus classic controls composed of adjacent normal tissue revealed distinct molecular signatures. Differential gene expression of TNBC compared with normal comparators demonstrated important findings for TNBC-specific clinical trials testing targeted agents; lack of over-expression for negative studies and over-expression in studies with drug activity. Next, by comparing each individual TNBC to the set of microdissected normals, we demonstrate that TNBC heterogeneity is attributable to transcriptional chaos, is associated with non-silent DNA mutational load, and explains transcriptional heterogeneity in addition to known molecular subtypes. Finally, chaos analysis identified 146 core genes dysregulated in >90 % of TNBCs revealing an over-expressed central network. In conclusion, use of microdissected normal ductal epithelium from healthy volunteers enables an optimized approach for studying TNBC and uncovers biological heterogeneity mediated by transcriptional chaos.

Original languageEnglish
Pages (from-to)57-68
Number of pages12
JournalBreast Cancer Research and Treatment
Volume143
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Triple Negative Breast Neoplasms
RNA Sequence Analysis
Epithelium
Healthy Volunteers
Tissue Banks
Neoplasms
Atlases
Transcriptome
Pharmaceutical Preparations
Breast
Clinical Trials
Genome

Keywords

  • Adjacent normal
  • Ductal epithelium
  • Normal breast
  • RNA-seq
  • TCGA
  • Triple-negative breast cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing. / Radovich, Milan; Clare, Susan E.; Atale, Rutuja; Pardo, Ivanesa; Hancock, Bradley A.; Solzak, Jeffrey P.; Kassem, Nawal; Mathieson, Theresa; Storniolo, Anna Maria; Rufenbarger, Connie; Lillemoe, Heather A.; Blosser, Rachel J.; Choi, Mi Ran; Sauder, Candice A.; Doxey, Diane; Henry, Jill E.; Hilligoss, Eric E.; Sakarya, Onur; Hyland, Fiona C.; Hickenbotham, Matthew; Zhu, Jin; Glasscock, Jarret; Badve, Sunil; Ivan, Mircea; Liu, Yunlong; Sledge, George W.; Schneider, Bryan.

In: Breast Cancer Research and Treatment, Vol. 143, No. 1, 01.2014, p. 57-68.

Research output: Contribution to journalArticle

Radovich, M, Clare, SE, Atale, R, Pardo, I, Hancock, BA, Solzak, JP, Kassem, N, Mathieson, T, Storniolo, AM, Rufenbarger, C, Lillemoe, HA, Blosser, RJ, Choi, MR, Sauder, CA, Doxey, D, Henry, JE, Hilligoss, EE, Sakarya, O, Hyland, FC, Hickenbotham, M, Zhu, J, Glasscock, J, Badve, S, Ivan, M, Liu, Y, Sledge, GW & Schneider, B 2014, 'Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing', Breast Cancer Research and Treatment, vol. 143, no. 1, pp. 57-68. https://doi.org/10.1007/s10549-013-2780-y
Radovich, Milan ; Clare, Susan E. ; Atale, Rutuja ; Pardo, Ivanesa ; Hancock, Bradley A. ; Solzak, Jeffrey P. ; Kassem, Nawal ; Mathieson, Theresa ; Storniolo, Anna Maria ; Rufenbarger, Connie ; Lillemoe, Heather A. ; Blosser, Rachel J. ; Choi, Mi Ran ; Sauder, Candice A. ; Doxey, Diane ; Henry, Jill E. ; Hilligoss, Eric E. ; Sakarya, Onur ; Hyland, Fiona C. ; Hickenbotham, Matthew ; Zhu, Jin ; Glasscock, Jarret ; Badve, Sunil ; Ivan, Mircea ; Liu, Yunlong ; Sledge, George W. ; Schneider, Bryan. / Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing. In: Breast Cancer Research and Treatment. 2014 ; Vol. 143, No. 1. pp. 57-68.
@article{0fdf387f01474e748bfff6908e668181,
title = "Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing",
abstract = "Triple-negative breast cancers (TNBCs) are a heterogeneous set of tumors defined by an absence of actionable therapeutic targets (ER, PR, and HER-2). Microdissected normal ductal epithelium from healthy volunteers represents a novel comparator to reveal insights into TNBC heterogeneity and to inform drug development. Using RNA-sequencing data from our institution and The Cancer Genome Atlas (TCGA) we compared the transcriptomes of 94 TNBCs, 20 microdissected normal breast tissues from healthy volunteers from the Susan G. Komen for the Cure Tissue Bank, and 10 histologically normal tissues adjacent to tumor. Pathway analysis comparing TNBCs to optimized normal controls of microdissected normal epithelium versus classic controls composed of adjacent normal tissue revealed distinct molecular signatures. Differential gene expression of TNBC compared with normal comparators demonstrated important findings for TNBC-specific clinical trials testing targeted agents; lack of over-expression for negative studies and over-expression in studies with drug activity. Next, by comparing each individual TNBC to the set of microdissected normals, we demonstrate that TNBC heterogeneity is attributable to transcriptional chaos, is associated with non-silent DNA mutational load, and explains transcriptional heterogeneity in addition to known molecular subtypes. Finally, chaos analysis identified 146 core genes dysregulated in >90 {\%} of TNBCs revealing an over-expressed central network. In conclusion, use of microdissected normal ductal epithelium from healthy volunteers enables an optimized approach for studying TNBC and uncovers biological heterogeneity mediated by transcriptional chaos.",
keywords = "Adjacent normal, Ductal epithelium, Normal breast, RNA-seq, TCGA, Triple-negative breast cancer",
author = "Milan Radovich and Clare, {Susan E.} and Rutuja Atale and Ivanesa Pardo and Hancock, {Bradley A.} and Solzak, {Jeffrey P.} and Nawal Kassem and Theresa Mathieson and Storniolo, {Anna Maria} and Connie Rufenbarger and Lillemoe, {Heather A.} and Blosser, {Rachel J.} and Choi, {Mi Ran} and Sauder, {Candice A.} and Diane Doxey and Henry, {Jill E.} and Hilligoss, {Eric E.} and Onur Sakarya and Hyland, {Fiona C.} and Matthew Hickenbotham and Jin Zhu and Jarret Glasscock and Sunil Badve and Mircea Ivan and Yunlong Liu and Sledge, {George W.} and Bryan Schneider",
year = "2014",
month = "1",
doi = "10.1007/s10549-013-2780-y",
language = "English",
volume = "143",
pages = "57--68",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing

AU - Radovich, Milan

AU - Clare, Susan E.

AU - Atale, Rutuja

AU - Pardo, Ivanesa

AU - Hancock, Bradley A.

AU - Solzak, Jeffrey P.

AU - Kassem, Nawal

AU - Mathieson, Theresa

AU - Storniolo, Anna Maria

AU - Rufenbarger, Connie

AU - Lillemoe, Heather A.

AU - Blosser, Rachel J.

AU - Choi, Mi Ran

AU - Sauder, Candice A.

AU - Doxey, Diane

AU - Henry, Jill E.

AU - Hilligoss, Eric E.

AU - Sakarya, Onur

AU - Hyland, Fiona C.

AU - Hickenbotham, Matthew

AU - Zhu, Jin

AU - Glasscock, Jarret

AU - Badve, Sunil

AU - Ivan, Mircea

AU - Liu, Yunlong

AU - Sledge, George W.

AU - Schneider, Bryan

PY - 2014/1

Y1 - 2014/1

N2 - Triple-negative breast cancers (TNBCs) are a heterogeneous set of tumors defined by an absence of actionable therapeutic targets (ER, PR, and HER-2). Microdissected normal ductal epithelium from healthy volunteers represents a novel comparator to reveal insights into TNBC heterogeneity and to inform drug development. Using RNA-sequencing data from our institution and The Cancer Genome Atlas (TCGA) we compared the transcriptomes of 94 TNBCs, 20 microdissected normal breast tissues from healthy volunteers from the Susan G. Komen for the Cure Tissue Bank, and 10 histologically normal tissues adjacent to tumor. Pathway analysis comparing TNBCs to optimized normal controls of microdissected normal epithelium versus classic controls composed of adjacent normal tissue revealed distinct molecular signatures. Differential gene expression of TNBC compared with normal comparators demonstrated important findings for TNBC-specific clinical trials testing targeted agents; lack of over-expression for negative studies and over-expression in studies with drug activity. Next, by comparing each individual TNBC to the set of microdissected normals, we demonstrate that TNBC heterogeneity is attributable to transcriptional chaos, is associated with non-silent DNA mutational load, and explains transcriptional heterogeneity in addition to known molecular subtypes. Finally, chaos analysis identified 146 core genes dysregulated in >90 % of TNBCs revealing an over-expressed central network. In conclusion, use of microdissected normal ductal epithelium from healthy volunteers enables an optimized approach for studying TNBC and uncovers biological heterogeneity mediated by transcriptional chaos.

AB - Triple-negative breast cancers (TNBCs) are a heterogeneous set of tumors defined by an absence of actionable therapeutic targets (ER, PR, and HER-2). Microdissected normal ductal epithelium from healthy volunteers represents a novel comparator to reveal insights into TNBC heterogeneity and to inform drug development. Using RNA-sequencing data from our institution and The Cancer Genome Atlas (TCGA) we compared the transcriptomes of 94 TNBCs, 20 microdissected normal breast tissues from healthy volunteers from the Susan G. Komen for the Cure Tissue Bank, and 10 histologically normal tissues adjacent to tumor. Pathway analysis comparing TNBCs to optimized normal controls of microdissected normal epithelium versus classic controls composed of adjacent normal tissue revealed distinct molecular signatures. Differential gene expression of TNBC compared with normal comparators demonstrated important findings for TNBC-specific clinical trials testing targeted agents; lack of over-expression for negative studies and over-expression in studies with drug activity. Next, by comparing each individual TNBC to the set of microdissected normals, we demonstrate that TNBC heterogeneity is attributable to transcriptional chaos, is associated with non-silent DNA mutational load, and explains transcriptional heterogeneity in addition to known molecular subtypes. Finally, chaos analysis identified 146 core genes dysregulated in >90 % of TNBCs revealing an over-expressed central network. In conclusion, use of microdissected normal ductal epithelium from healthy volunteers enables an optimized approach for studying TNBC and uncovers biological heterogeneity mediated by transcriptional chaos.

KW - Adjacent normal

KW - Ductal epithelium

KW - Normal breast

KW - RNA-seq

KW - TCGA

KW - Triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84892799530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892799530&partnerID=8YFLogxK

U2 - 10.1007/s10549-013-2780-y

DO - 10.1007/s10549-013-2780-y

M3 - Article

C2 - 24292813

AN - SCOPUS:84892799530

VL - 143

SP - 57

EP - 68

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -